What EPR means for the medical industry

Extended Producer Responsibility places legal and financial responsibility on producers to manage post-consumer waste. Under mandatory EPR schemes, manufacturers must:

• Ensure proper collection and recycling or recovery of products after use, reducing landfill and incineration dependency.
• Design products for better recyclability, minimal waste, and lower environmental impact.
• Report transparently on waste streams and recycling performance, supporting national circular economy goals.

Traditionally applied to packaging, electronics, and batteries, EPR is now expanding into medical products and packaging — a sector with inherently complex requirements for sterility, safety, and regulated disposal. As health systems worldwide adopt net-zero strategies, plastics reduction targets, and circular procurement policies, EPR presents a credible mechanism to drive environmental accountability within medical supply value chains.

Mandatory EPR frameworks are gaining traction globally. The European Union’s Packaging and Packaging Waste Regulation (PPWR) updates and national EPR systems in countries like France, Germany and South Korea signal a broader shift toward producer responsibility. These policies aim to reduce waste generation and increase recycling rates — goals that align with healthcare systems’ environmental performance priorities.

Why EPR matters for healthcare sustainability

Healthcare generates significant waste — including medical device packaging, single-use plastics, and regulated clinical materials — which often end up in incineration or specialised treatment streams. EPR can help the medical industry:

• Reduce environmental footprint by incentivising the design of reusable, recyclable, and low-impact products.
• Lower system waste management costs as producers share responsibility for collection, treatment and recycling.
• Increase supply chain transparency, enabling hospitals and payers to make environmentally informed procurement decisions.

Under mandatory EPR, producers of medical devices, consumables, and packaging would be required to fund or operate recycling and recovery systems. This encourages upstream design innovations, such as modular or sterilisation-compatible product components, that improve the potential for reuse and recyclability — a valuable asset for healthcare providers seeking both sustainability and operational efficiency.

What this means for policy and industry collaboration

The rising momentum for mandatory EPR reflects broader government commitments to circular economies and emissions reduction. In the UAE and the Gulf Cooperation Council (GCC), national strategies increasingly emphasise sustainability across sectors, including healthcare. Introducing clear EPR frameworks for medical products would support these goals while encouraging international manufacturers to harmonise designs with regional environmental standards.

For industry leaders and healthcare systems, engaging early with EPR policy development can yield competitive advantages — encouraging sustainable innovation, enhancing brand reputation, and supporting compliance in global markets where EPR is already taking shape.

Conclusion

Mandatory Extended Producer Responsibility (EPR) stands as a policy lever with significant potential to transform the medical industry in 2026 and beyond. By aligning producer accountability with environmental performance, EPR can reduce waste, drive sustainable product design, and support the broader transition toward circular healthcare systems — benefiting patients, providers, and planetary health alike.